Compliance to glaucoma topical therapy and barriers to glaucoma surgery acceptance in a tertiary hospital, Nigeria
DOI:
https://doi.org/10.18203/2349-2902.isj20260454Keywords:
Compliance,, Intraocular pressure, Trabeculectomy acceptanceAbstract
Background: Glaucoma is a leading cause of irreversible blindness globally. Intraocular pressure (IOP) is the only modifiable factor in the management of glaucoma patients in order to slow down the disease progression. Poor compliance, uncontrolled IOP despite adequate topical therapy and patients’ preference were indications for surgical intervention. The aim of the study is to determine compliance to topical glaucoma therapy, acceptance of glaucoma surgery and its barriers with a view to improve glaucoma surgery acceptance.
Methods: This was a hospital-based longitudinal study. Ninety-six primary open angle glaucoma patients were surveyed for compliance to medication and acceptance of glaucoma surgery. Morisky Medication Adherence Scale item 8 (MMAS-8) and visual analogue scale (VAS) was used as tool in assessing the compliance level. A pretested semi-structured interviewer administered questionnaire was used to assess the socio-demographics, compliance to medication, glaucoma surgery awareness and barriers to glaucoma surgery acceptance. All participants were counseled and also grouped based on gender for group discussion as means of intervention. Results were presented in frequency tables, figures and charts. The statistical significance level was set at p<0.05%.
Results: At baseline, 35.40% of the participants were compliant to medications with MMAS-8 (VAS; 51%). With intervention (counseling and group discussion), at 180 days 76.00% of the participants were compliant to antiglaucoma medications. At baseline and 180 days, 18 (19%) and 25 (26.04%) participants were willing to undergo glaucoma surgery respectively, 5 (20%) out of 25 (26.04%) participants willing to undergo glaucoma surgery accepted trabeculectomy. Fifty-one out of 96 participants have heard of glaucoma surgery at baseline.
Conclusions: There was an improvement in compliance to medication, willingness to undergo glaucoma surgery and acceptance of trabeculectomy following counseling and group discussion.
Metrics
References
Quigley A, Broman AT. The number of people with Glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:266. DOI: https://doi.org/10.1136/bjo.2005.081224
Sandford-Smith J. Glaucoma. In: Butterworth Heinemann, editor. Eye diseases in hot climates, 4th ed. New Delhi: Elsevier: 2003; 299-305.
Kyari F, Entekume G, Rabiu M, Spry P, Wormald R, Nolan W, et al. A population- based survey of the prevalence and types of Glaucoma in Nigeria: results from the Nigeria national Blindness and visual impairment survey. BMC Ophthal. 2015;15:176. DOI: https://doi.org/10.1186/s12886-015-0160-6
Leske MC, Heijl A, Hyman L, Bengtsson B. Early manifest Glaucoma trial: design and baseline data. Ophthalmology. 1999;106(11):2144-53. DOI: https://doi.org/10.1016/S0161-6420(99)90497-9
Heijl A, Leske MC, Bengtsson B, Hussein M. Early manifest Glaucoma Trial group. Reduction of intraocular pressure and glaucoma progression: results from the early manifest Glaucoma trial. Arch Ophthalmol. 2002;120(10):1268-79. DOI: https://doi.org/10.1001/archopht.120.10.1268
Skalicky SE, Goldberg I. Adherence and persistence: The challenges for Glaucoma medical therapy. Asia – Pacific J Ophthamol. 2013;2(6). DOI: https://doi.org/10.1097/APO.0000000000000023
Bowman R, Kirupananthan S. How to manage a patient with glaucoma in Africa. Community Eye Health J. 2006;19(59):38-9.
Thommy CP, Bhar I. Trabeculectomy in Nigerian patients with open angle glaucoma. Br J Ophthalmol. 1979;63:636-42.
Adegbehingbe B, Majemgbasan T. A review of Trabeculectomies at a Nigerian Teaching Hospital. Ghana Med J. 2007;41:176-80.
Adekoya BJ, Akinsola FB, Balogun BG, Balogun MM, Ibidapo OO. Patient Refusal of Glaucoma surgery and associated factors in Lagos, Nigeria. Middle East Afr J Ophthalmol. 2013;20(2):168-73. DOI: https://doi.org/10.4103/0974-9233.110612
Abdull MM, Gulbert CC, Evans J. Primary Open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol. 2015;15:111.
Plakas S, Mastrogiannis D, Mantzorou M, Adamakidou T, Fouka G, Bouziou A, et al. Validation of the 8-Item Morisky Medication Adherence Scale in Chronically ill Ambulatory patients in Rural Greece. Open J Nursing. 2016;6:158-69.
Ronald L, Fellman, Mattox CG, Kim M. Knows the new glaucoma staging codes. Eye Net magazine. 2011. Available from: http://www.aao.org> eyenet>article>K. Accessed on 02 January 2026.
Patel SC, Spaeth GL. Compliance in patients prescribed eye drops for Glaucoma. Ophthalmic Surg. 1995;26(3):233-6. DOI: https://doi.org/10.3928/1542-8877-19950501-14
Tesfay M, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agent and its determinant factors among glaucoma patients in Menelik II referral hospital, Ethiopia. BMC Ophthalmology. 2016;16:25-8. DOI: https://doi.org/10.1186/s12886-016-0316-z
Onakoya AO, Mbadugha CA. Self-reported adherence rates in glaucoma patients in south west Nigeria. Journal of Clinical science 2016;13:51-7. DOI: https://doi.org/10.4103/2408-7408.179649
Omoti AE, Ukponmwan CU. Compliance with new drugs in glaucoma therapy in Benin City, Nigeria. Seiguimiento Farmacoterapeutico. 2005;3(3):135-43. DOI: https://doi.org/10.4103/1117-1936.175282
Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K, et al. The relationship between glaucoma medication adherence, eye drop technique & visual field defect severity. Ophthalmology 2011;118(12):2398-402. DOI: https://doi.org/10.1016/j.ophtha.2011.05.013
Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in a collaborative initial glaucoma treatment study. J Ophth. 2019;10:22.
Okeke CO, Quigley HA, Jampel HD. Adherence with topical glaucoma medication monitored electronically the travatan dosing Aid study. Ophthalmology 2009;116:191-9. DOI: https://doi.org/10.1016/j.ophtha.2008.09.004
Rait JL, Adena MA. Persistency rates for prostagladin and other hypotensive eye drops: Population based study using pharmacy claims data. Clin experiment Ophthalmol. 2007;35:602-11. DOI: https://doi.org/10.1111/j.1442-9071.2007.01564.x
Morisky DE, Green LW, Levine DM. Concurrent and Predictive validity of a self-reported measure of medication adherence. Medcare. 1986;24(1):67-74. DOI: https://doi.org/10.1097/00005650-198601000-00007
Plakas S, Mastrogiannis D, Mantzorou M, Adamakidou T, Fouka G, Bouziou A, et al. Validation of the 8-Item Morisky Medication Adherence Scale in Chronically ill Ambulatory patients in Rural Greece. Open Journal of Nursing 2016;6:158-69. DOI: https://doi.org/10.4236/ojn.2016.63017
Bowman R, Kirupananthan S. How to manage a patient with glaucoma in Africa. Community Eye Health J. 2006;19(59):38-9. DOI: https://doi.org/10.1016/S0840-4704(10)60081-6
Thommy CP, Bhar I. Trabeculectomy in Nigerian patients with open angle glaucoma. Br J Ophthalmol. 1979;63:636-42. DOI: https://doi.org/10.1136/bjo.63.9.636
Adegbehingbe B, Majemgbasan T. A review of Trabeculectomies at a Nigerian Teaching Hospital. Ghana Med J. 2007;41:176-80. DOI: https://doi.org/10.4314/gmj.v41i4.55287
Kim HY, Egbert PR, Singh K. Long Term comparison of primary Trabeculectomy with 5–fluorouracil versus mitomycin C in West Africa. J Glaucoma. 2008;17(7):578–83. DOI: https://doi.org/10.1097/IJG.0b013e31816b304a
Kanski JJ, Bowling B, Nischal K, Pearson A. Glaucoma. In: Elsevier, editor. Clinical Ophthalmology: A systematic approach, 8th ed. China: Elsevier Saunders; 2011: 307-358. DOI: https://doi.org/10.1016/B978-0-7020-4093-1.00010-0
Abdull MM, Gulbert CC, Evans J. Primary Open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol. 2015;15:111. DOI: https://doi.org/10.1186/s12886-015-0097-9
Omoti AE, Edema OT, Waziri-Erameh MJM. Acceptability of surgery as initial treatment for primary open angle glaucoma. Jnl medicine & Biomedical Res. 2002;1(1):68-7. DOI: https://doi.org/10.4314/jmbr.v1i1.10650